Shares of Hypermarcas (OTCMKTS:HYPMY - Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $4.78, but opened at $5.00. Hypermarcas shares last traded at $5.00, with a volume of 2,980 shares traded.
Hypermarcas Price Performance
The company's 50-day simple moving average is $4.62 and its 200-day simple moving average is $3.79. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80. The stock has a market capitalization of $2.94 billion, a price-to-earnings ratio of 19.33 and a beta of 0.81.
Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $184.34 million for the quarter. Hypermarcas had a return on equity of 6.95% and a net margin of 12.51%.
Hypermarcas Announces Dividend
The firm also recently announced a dividend, which will be paid on Friday, January 8th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.0345 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a dividend yield of 2.81%. Hypermarcas's dividend payout ratio is presently 58.33%.
Hypermarcas Company Profile
(
Get Free Report)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
Before you consider Hypermarcas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.
While Hypermarcas currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
